1,730
Views
2
CrossRef citations to date
0
Altmetric
Reviews

The Association between Fat-Free Mass and Exercise Test Outcomes in People with Chronic Obstructive Pulmonary Disease: A Systematic Review

, , , , , , , & ORCID Icon show all
Pages 182-205 | Received 10 Jan 2022, Accepted 23 Feb 2022, Published online: 12 Apr 2022

References

  • Vogelmeier C, Agusti A, Anzueto A. GOLD Science Committe Members. Global Strategy for Diagnosis, Management and Prevention of COPD (2021 Report). © 2020, Global Initiative for Chronic Obstructive Lung Disease, available from www.goldcopd.org, published in Fontana, WI, USA.
  • Chronic Obstructive Pulmonary Disease Among Adults — United States, 2011. Centers for Disease Control and Prevention (CDC); 2012. [cited 2020]. https://www.cdc.gov/mmwr/preview/mmwrhtml/mm6146a2.htm.
  • Agusti AG. Systemic effects of chronic obstructive pulmonary disease. Proc Am Thorac Soc. 2005;2(4):367–370. DOI:10.1513/pats.200504-026SR
  • Barnes PJ, Celli BR. Systemic manifestations and comorbidities of COPD. Eur Respir J. 2009;33(5):1165–1185. DOI:10.1183/09031936.00128008
  • Maltais F, Decramer M, Casaburi R, ATS/ERS Ad Hoc Committee on Limb Muscle Dysfunction in COPD, et al. An official American Thoracic Society/European Respiratory Society statement: update on limb muscle dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2014;189(9):e15-62–e62. DOI:10.1164/rccm.201402-0373ST
  • Limpawattana P, Inthasuwan P, Putraveephong S, et al. Sarcopenia in chronic obstructive pulmonary disease: a study of prevalence and associated factors in the Southeast Asian population. Chron Respir Dis. 2018;15(3):250–257. DOI:10.1177/1479972317743759
  • Shrikrishna D, Patel M, Tanner RJ, et al. Quadriceps wasting and physical inactivity in patients with COPD. Eur Respir J. 2012;40(5):1115–1122. DOI:10.1183/09031936.00170111
  • Mathur S, Brooks D, Carvalho CR. Structural alterations of skeletal muscle in COPD. Front Physiol. 2014;5(104):104.
  • Vogelmeier CF, Criner GF, Martinez FJ, et al. Global Strategy for the Diagnosis, Management, and Prevention of Chronic Obstructive Lung Disease 2017 Report. GOLD Executive Summary. Am J Respir Crit Care Med. 2017;195(5):557–582. DOI:10.1164/rccm.201701-0218PP
  • Schols AM, Mostert R, Soeters PB, et al. Body composition and exercise performance in patients with chronic obstructive pulmonary disease. Thorax. 1991;46(10):695–699. DOI:10.1136/thx.46.10.695
  • Yoshimura K, Sato S, Muro S, et al. Interdependence of physical inactivity, loss of muscle mass and low dietary intake: Extrapulmonary manifestations in older chronic obstructive pulmonary disease patients. Geriatr Gerontol Int. 2018;18(1):88–94. DOI:10.1111/ggi.13146
  • Koo HK, Park JH, Park HK, et al. Conflicting role of sarcopenia and obesity in male patients with chronic obstructive pulmonary disease: Korean national health and nutrition examination survey. PLoS One. 2014;9(10):e110448. DOI:10.1371/journal.pone.0110448
  • Marco E, Sanchez-Rodriguez D, Davalos-Yerovi VN, et al. Malnutrition according to ESPEN consensus predicts hospitalizations and long-term mortality in rehabilitation patients with stable chronic obstructive pulmonary disease. Clin Nutr. 2019;38(5):2180–2186. DOI:10.1016/j.clnu.2018.09.014
  • Marquis K, Debigare R, Lacasse Y, et al. Midthigh muscle cross-sectional area is a better predictor of mortality than body mass index in patients with chronic obstructive pulmonary disease. Am J Respir Crit Care Med. 2002;166(6):809–813. DOI:10.1164/rccm.2107031
  • Franssen FM, Broekhuizen R, Janssen PP, et al. Effects of whole-body exercise training on body composition and functional capacity in normal-weight patients with COPD. Chest. 2004;125(6):2021–2028. DOI:10.1378/chest.125.6.2021
  • Ischaki E, Papatheodorou G, Gaki E, et al. Body mass and fat-free mass indices in COPD: relation with variables expressing disease severity. Chest. 2007;132(1):164–169. DOI:10.1378/chest.06-2789
  • Casaburi R. Combination therapy for exercise intolerance in COPD. Thorax. 2006;61(7):551–552. DOI:10.1136/thx.2006.058511
  • Pinto-Plata VM, Cote C, Cabral H, et al. The 6-min walk distance: change over time and value as a predictor of survival in severe COPD. Eur Respir J. 2004;23(1):28–33. DOI:10.1183/09031936.03.00034603
  • Oga T, Nishimura K, Tsukino M, et al. Analysis of the factors related to mortality in chronic obstructive pulmonary disease: role of exercise capacity and health status. Am J Respir Crit Care Med. 2003;167(4):544–549. DOI:10.1164/rccm.200206-583OC
  • Schols AMWJ, Mostert R, Soeters PB, et al. Nutritional state and exercise performance in patients with chronic obstructive lung disease. Thorax. 1989;44(11):937–941. DOI:10.1136/thx.44.11.937
  • Schols AMWJ, Soeters PB, Dingemans AMC, et al. Prevalence and characteristics of nutritional depletion in patients with stable COPD eligible for pulmonary rehabilitation. Am Rev Respir Dis. 1993;147(5):1151–1156. DOI:10.1164/ajrccm/147.5.1151
  • Shoup R, Dalsky G, Warner S, et al. Body composition and health-related quality of life in patients with obstructive airways disease. Eur Respir J. 1997;10(7):1576–1580. DOI:10.1183/09031936.97.10071576
  • Baarends EM, Schols AM, Mostert R, et al. Peak exercise response in relation to tissue depletion in patients with chronic obstructive pulmonary disease. Eur Respir J. 1997;10(12):2807–2813. DOI:10.1183/09031936.97.10122807
  • Yoshikawa M, Yoneda T, Kobayashi A, et al. Body composition analysis by dual energy X-ray absorptiometry and exercise performance in underweight patients with COPD. Chest. 1999;115(2):371–375. DOI:10.1378/chest.115.2.371
  • Kobayashi A, Yoneda T, Yoshikawa M, et al. The relation of fat-free mass to maximum exercise performance in patients with chronic obstructive pulmonary disease. Lung. 2000;178(2):119–127. DOI:10.1007/s004080000014
  • Mostert R, Goris A, Weling-Scheepers C, et al. Tissue depletion and health related quality of life in patients with chronic obstructive pulmonary disease. Respir Med. 2000;94(9):859–867. DOI:10.1053/rmed.2000.0829
  • Yoshikawa M, Yoneda T, Takenaka H, et al. Distribution of muscle mass and maximal exercise performance in patients with COPD. Chest. 2001;119(1):93–98. DOI:10.1378/chest.119.1.93
  • Gosker HR, Lencer NHMK, Franssen FME, et al. Striking similarities in systemic factors contributing to decreased exercise capacity in patients with severe chronic heart failure or COPD. Chest. 2003;123(5):1416–1424. DOI:10.1378/chest.123.5.1416
  • Mamoto T, Fujiwara H, Toyama Y, et al. Relationship between exercise performance and water distribution measured by new bioelectrical impedance analysis in patients with chronic obstructive pulmonary disease. Clin Physiol Funct Imaging. 2003;23(4):230–235. DOI:10.1046/j.1475-097X.2003.00502.x
  • Franssen FM, Broekhuizen R, Janssen PP, et al. Limb muscle dysfunction in COPD: effects of muscle wasting and exercise training. Med Sci Sports Exerc. 2005;37(1):2–9.
  • Steiner M, Singh SJ, Morgan MDL. The contribution of peripheral muscle function to shuttle walking performance in patients with chronic obstructive pulmonary disease. J Cardiopulm Rehabil. 2005;25:43–49.
  • Mathew JT, Gv V, Kurpad AV, et al. Nutritional status predicts outcomes in patients hospitalised with exacerbations of COPD. Lung India. 2006;23(4):143–146. DOI:10.4103/0970-2113.44387
  • Eisner MD, Blanc PD, Sidney S, et al. Body composition and functional limitation in COPD. Respir Res. 2007;8:7. DOI:10.1186/1465-9921-8-7
  • Villaca DS, Lerario MC, Dal Corso S, et al. Clinical value of anthropometric estimates of leg lean volume in nutritionally depleted and non-depleted patients with chronic obstructive pulmonary disease. Br J Nutr. 2008;100(2):380–386. DOI:10.1017/S0007114507886399
  • Budweiser S, Meyer K, Jorres RA, et al. Nutritional depletion and its relationship to respiratory impairment in patients with chronic respiratory failure due to COPD or restrictive thoracic diseases. Eur J Clin Nutr. 2008;62(3):436–443. DOI:10.1038/sj.ejcn.1602708
  • Franssen FM, Sauerwein HP, Rutten EP, et al. Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD. Eur Respir J. 2008;32(6):1466–1471. DOI:10.1183/09031936.00014008
  • van Wetering CR, van Nooten FE, Mol SJM, et al. Systemic impairment in relation to disease burden in patients with moderate COPD eligble for lifestyle program. Findings from the INTERCOM trial. COPD. 2008;3:443–451. DOI:10.2147/COPD.S2588
  • Vilaro J, Rabinovich R, Gonzalez-deSuso JM, et al. Clinical assessment of peripheral muscle function in patients with chronic obstructive pulmonary disease. Am J Phys Med Rehabil. 2009;88(1):39–46. DOI:10.1097/PHM.0b013e31818dff86
  • Pelegrino NRG, Lucheta PA, Sanchez FF, et al. Influence of lean body mass on cardiopulmonary repercussions during the six-minute walk test in patients with COPD. J Bras Pneumol. 2009;35(1):20–26. DOI:10.1590/s1806-37132009000100004
  • Giron R, Matesanz C, Garcia-Rio F, et al. Nutritional state during COPD exacerbation: clinical and prognostic implications. Ann Nutr Metab. 2009;54(1):52–58. DOI:10.1159/000205960
  • Vogiatzis I, Simoes DC, Stratakos G, et al. Effect of pulmonary rehabilitation on muscle remodelling in cachectic patients with COPD. Eur Respir J. 2010;36(2):301–310. DOI:10.1183/09031936.00112909
  • Sabino PG, Silva BM, Brunetto AF. Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients. Clinics. 2010;65(6):599–605. DOI:10.1590/S1807-59322010000600007
  • Cortopassi F, Divo M, Pinto-Plata V, et al. Resting handgrip force and impaired cardiac function at rest and during exercise in COPD patients. Respir Med. 2011;105(5):748–754. DOI:10.1016/j.rmed.2010.12.011
  • Hallin R, Janson C, Arnardottir RH, et al. Relation between physical capacity, nutritional status and systemic inflammation in COPD. Clin Respir J. 2011;5(3):136–142. DOI:10.1111/j.1752-699X.2010.00208.x
  • Malaguti C, Napolis LM, Villaca D, et al. Relationship between peripheral muscle structure and function in patients with chronic obstructive pulmonary disease with different nutritional status. J Strength Cond Res. 2011;25(7):1795–1803. DOI:10.1519/JSC.0b013e3181e501c1
  • Waatevik M, Johannessen A, Hardie JA, et al. Different COPD disease characteristics are related to different outcomes in the 6-minute walk test. COPD. 2012;9(3):227–234. DOI:10.3109/15412555.2011.650240
  • Fermoselle C, Rabinovich R, Ausin P, et al. Does oxidative stress modulate limb muscle atrophy in severe COPD patients? Eur Respir J. 2012;40(4):851–862. DOI:10.1183/09031936.00137211
  • Cesari M, Pedone C, Chiurco D, et al. Physical performance, sarcopenia and respiratory function in older patients with chronic obstructive pulmonary disease. Age Ageing. 2012;41(2):237–241. DOI:10.1093/ageing/afr167
  • Hillman CM, Heinecke EL, Hii JW, et al. Relationship between body composition, peripheral muscle strength and functional exercise capacity in patients with severe chronic obstructive pulmonary disease. Intern Med J. 2012;42(5):578–581. DOI:10.1111/j.1445-5994.2012.02771.x
  • Roca M, Mitu F, Roca I, et al. Body composition alterations in chronic obstructive pulmonary disease. Rev Med Chir Soc Med Nat Iasi. 2013;117(1):29–35.
  • Berton DC, Silveira L, Da Costa CC, et al. Effectiveness of pulmonary rehabilitation in exercise capacity and quality of life in chronic obstructive pulmonary disease patients with and without global fat-free mass depletion. Arch Phys Med Rehabil. 2013;94(8):1607–1614. DOI:10.1016/j.apmr.2013.02.005
  • Natanek SA, Riddoch-Contreras J, Marsh GS, et al. MuRF-1 and atrogin-1 protein expression and quadriceps fiber size and muscle mass in stable patients with COPD. COPD. 2013;10(5):618–624. DOI:10.3109/15412555.2013.781577
  • Genc A, Ucok K, Sener U, et al. Association analyses of oxidative stress, aerobic capacity, daily physical activity, and body composition parameters in patients with mild to moderate COPD. Turk J Med Sci. 2014;44(6):972–979.
  • Teopompi E, Tzani P, Aiello M, et al. Fat-free mass depletion is associated with poor exercise capacity irrespective of dynamic hyperinflation in COPD patients. Respir Care. 2014;59(5):718–725. DOI:10.4187/respcare.02709
  • Aiello M, Teopompi E, Tzani P, et al. Maximal exercise in obese patients with COPD: the role of fat free mass. BMC Pulm Med. 2014;14(1):96. DOI:10.1186/1471-2466-14-96
  • Frisk B, Espehaug B, Hardie JA, et al. Physical activity and longitudinal change in 6-min walk distance in COPD patients. Respir Med. 2014;108(1):86–94. DOI:10.1016/j.rmed.2013.09.004
  • McDonald ML, Diaz AA, Ross JC, et al. Quantitative computed tomography measures of pectoralis muscle area and disease severity in chronic obstructive pulmonary disease. A cross-sectional study. Annals ATS. 2014;11(3):326–334. DOI:10.1513/AnnalsATS.201307-229OC
  • Silveira L, Teixeira PJ, da Costa CC, et al. The relationship between fat-free mass index and pulmonary hyperinflation in COPD patients. Respirology. 2014;19(8):1204–1208. DOI:10.1111/resp.12406
  • Robles PG, Sussman MS, Naraghi A, et al. Intramuscular fat infiltration contributes to impaired muscle function in COPD. Med Sci Sports Exerc. 2015;47(7):1334–1341. DOI:10.1249/MSS.0000000000000556
  • van de Bool C, Rutten EP, Franssen FM, et al. Antagonistic implications of sarcopenia and abdominal obesity on physical performance in COPD. Eur Respir J. 2015;46(2):336–345. DOI:10.1183/09031936.00197314
  • Maddocks M, Kon SS, Jones SE, et al. Bioelectrical impedance phase angle relates to function, disease severity and prognosis in stable chronic obstructive pulmonary disease. Clin Nutr. 2015;34(6):1245–1250. DOI:10.1016/j.clnu.2014.12.020
  • Ramos D, Bertolini GN, Leite MR, et al. Is dynamometry able to infer the risk of muscle mass loss in patients with COPD? Int J Chron Obstruct Pulmon Dis. 2015;10:1403–1407. DOI:10.2147/COPD.S69829
  • Jones SE, Maddocks M, Kon SS, et al. Sarcopenia in COPD: prevalence, clinical correlates and response to pulmonary rehabilitation. Thorax. 2015;70(3):213–218. DOI:10.1136/thoraxjnl-2014-206440
  • de Blasio F, de Blasio F, Miracco Berlingieri G, et al. Evaluation of body composition in COPD patients using multifrequency bioelectrical impedance analysis. COPD. 2016;11:2419–2426. DOI:10.2147/COPD.S110364
  • Luo Y, Zhou L, Li Y, et al. Fat-free mass index for evaluating the nutritional status and disease severity in COPD. Respir Care. 2016;61(5):680–688. DOI:10.4187/respcare.04358
  • Cebron Lipovec N, Schols AM, van den Borst B, et al. Sarcopenia in advanced COPD affects cardiometabolic risk reduction by Short-Term high-intensity pulmonary rehabilitation. J Am Med Dir Assoc. 2016;17(9):814–820. DOI:10.1016/j.jamda.2016.05.002
  • Joppa P, Tkacova R, Franssen FM, et al. Sarcopenic obesity, functional outcomes, and systemic inflammation in patients with chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2016;17(8):712–718. DOI:10.1016/j.jamda.2016.03.020
  • Martin M, Almeras N, Despres J, et al. Ectopic fat accumulation in patients with COPD: an ECLIPSE substudy. COPD. 2017;12:451–460. DOI:10.2147/COPD.S124750
  • Travassos A, Rodrigues A, Furlanetto KC, et al. Fat-free mass depletion in patients with COPD in Brazil: development of a new cutoff point and its relation with mortality and extrapulmonary manifestations. Eur J Clin Nutr. 2017;71(11):1285–1290. DOI:10.1038/ejcn.2017.105
  • Tunsupon P, Mador MJ. The influence of body composition on pulmonary rehabilitation outcomes in chronic obstructive pulmonary disease patients. Lung. 2017;195(6):729–738. DOI:10.1007/s00408-017-0053-y
  • Buttery SC, Mohan D, Fisk M, et al. Longitudinal follow-up of quadriceps strength and function in a COPD cohort after 3 years. Eur Respir J. 2017;50(2):1700707. DOI:10.1183/13993003.00707-2017
  • Matkovic Z, Cvetko D, Rahelic D, et al. Nutritional status of patients with chronic obstructive pulmonary disease in relation to their physical performance. COPD. 2017;14(6):626–634. DOI:10.1080/15412555.2017.1386643
  • Byun MK, Cho EN, Chang J, et al. Sarcopenia correlates with systemic inflammation in COPD. Int J Chron Obstruct Pulmon Dis. 2017;12:669–675. DOI:10.2147/COPD.S130790
  • Ju S, Lee SJ, Park MJ, et al. Clinical importance of cross-sectional area of intercostal muscles in patients with chronic obstructive pulmonary disease. Clin Respir J. 2018;12(3):939–947. DOI:10.1111/crj.12609
  • Kapchinsky S, Vuda M, Miguez K, et al. Smoke-induced neuromuscular junction degeneration precedes the fibre type shift and atrophy in chronic obstructive pulmonary disease. J Physiol. 2018;596(14):2865–2881. DOI:10.1113/JP275558
  • Amado CA, Garcia-Unzueta MT, Lavin BA, et al. The ratio serum creatinine/serum cystatin C (a surrogate marker of muscle mass) as a predictor of hospitalization in chronic obstructive pulmonary disease outpatients. Respiration. 2019;97(4):302–309. DOI:10.1159/000494296
  • Nijholt W, Beek LT, Hobbelen JSM, et al. The added value of ultrasound muscle measurements in patients with COPD: an exploratory study. Clin Nutr ESPEN. 2019;30:152–158. DOI:10.1016/j.clnesp.2019.01.001
  • Machado FVC, Schneider LP, Fonseca J, et al. Clinical impact of body composition phenotypes in patients with COPD: a retrospective analysis. Eur J Clin Nutr. 2019;73(11):1512–1519. DOI:10.1038/s41430-019-0390-4
  • Chua JR, Albay AB, Jr., Tee ML. Body composition of Filipino chronic obstructive pulmonary disease (COPD) patients in relation to their lung function, exercise capacity and quality of life. Int J Chron Obstruct Pulmon Dis. 2019;14:2759–2765. DOI:10.2147/COPD.S222809
  • Kyomoto Y, Asai K, Yamada K, et al. Handgrip strength measurement in patients with chronic obstructive pulmonary disease: Possible predictor of exercise capacity. Respir Investig. 2019;57(5):499–505. DOI:10.1016/j.resinv.2019.03.014
  • Mansour KMK, Goulart CDL, Carvalho-Junior LCS, et al. Pulmonary function and functional capacity cut-off point to establish sarcopenia and dynapenia in patients with COPD. J Bras Pneumol. 2019;45(6):e20180252.
  • Kwan HY, Maddocks M, Nolan CM, et al. The prognostic significance of weight loss in chronic obstructive pulmonary disease-related cachexia: a prospective cohort study. J Cachexia Sarcopenia Muscle. 2019;10(6):1330–1338. DOI:10.1002/jcsm.12463
  • Cinar A, Arslan S, Demirel Y. The relationship of exercise capacity with fat-free mass and body mass index in elderly patients with chronic obstructive pulmonary disease. tjgeri. 2019;22(1):66–73. DOI:10.31086/tjgeri.2019150574
  • Demircioğlu H, Cihan FG, Kutlu R, et al. Frequency of sarcopenia and associated outcomes in patients with chronic obstructive pulmonary disease. Turk J Med Sci. 2020;50(5):1270–1279. DOI:10.3906/sag-1909-36
  • Perrot L, Greil A, Boirie Y, et al. Prevalence of sarcopenia and malnutrition during acute exacerbation of COPD and after 6 months recovery. Eur J Clin Nutr. 2020;74(11):1556–1564. DOI:10.1038/s41430-020-0623-6
  • Attaway AH, Welch N, Yadav R, et al. Quantitative computed tomography assessment of pectoralis and erector spinae muscle area and disease severity in chronic obstructive pulmonary disease referred for lung volume reduction. COPD: J Chronic Obstruct Pulmonary Dis. 2021;18(2):191–200. DOI:10.1080/15412555.2021.1897560
  • Bernardes S, Silva FM, da Costa CC, et al. Reduced calf circumference is an independent predictor of worse quality of life, severity of disease, frequent exacerbation, and death in patients with chronic obstructive pulmonary disease admitted to a pulmonary rehabilitation program: a historic cohort study. J Parenter Enteral Nutr. 2021;46(3):546–555. DOI:10.1002/jpen.2214
  • Donovan AA, Johnston G, Moore M, et al. Diaphragm morphology assessed by computed tomography in chronic obstructive pulmonary disease. Ann Am Thorac Soc. 2021;18(6):955–962. DOI:10.1513/AnnalsATS.202007-865OC
  • Fekete M, Fazekas-Pongor V, Balazs P, et al. Effect of malnutrition and body composition on the quality of life of COPD patients. PhysInt. 2021;108(2):238–250. DOI:10.1556/2060.2021.00170
  • Higashimoto Y, Shiraishi M, Sugiya R, et al. Effect of pulmonary rehabilitation on erector spinae muscles in individuals with COPD. Respir Care. 2021;66(9):1458–1468. DOI:10.4187/respcare.08678
  • Kanezaki M, Terada K, Tanabe N, et al. Effects of sarcopenia on ventilatory behavior and the multidimensional nature of dyspnea in patients with chronic obstructive pulmonary disease. J Am Med Dir Assoc. 2021;22(4):827–833. DOI:10.1016/j.jamda.2021.01.081
  • Lage VKS, Silva GP, Lacerda ACR, et al. Functional tests associated with sarcopenia in moderate chronic obstructive pulmonary disease. Expert Rev Respir Med. 2021;15(4):569–576. DOI:10.1080/17476348.2021.1850276
  • Machado FVC, Spruit MA, Groenen MTJ, et al. Frequency and functional translation of low muscle mass in overweight and obese patients with COPD. Respir Res. 2021;22(1):93. DOI:10.1186/s12931-021-01689-w
  • Mason SE, Moreta-Martinez R, Labaki WW, et al. Respiratory exacerbations are associated with muscle loss in current and former smokers. Thorax. 2021;76(6):554–560. DOI:10.1136/thoraxjnl-2020-215999
  • Mjid M, Hedhli A, Rouhou SC, et al. COPD patients’ body composition and its impact on lung function. Tunisie Med. 2021;99(2):285–290.
  • Schneider LP, Sartori LG, Machado FVC, et al. Physical activity and inactivity among different body composition phenotypes in individuals with moderate to very severe chronic obstructive pulmonary disease. Brazilian J Phys Ther. 2021;25(3):296–302. DOI:10.1016/j.bjpt.2020.07.005
  • Tashiro H, Takahashi K, Tanaka M, et al. Skeletal muscle is associated with exercise tolerance evaluated by cardiopulmonary exercise testing in Japanese patients with chronic obstructive pulmonary disease. Sci Rep. 2021;11(1):15862. DOI:10.1038/s41598-021-95413-9
  • Zanella PB, Avila CC, Chaves FC, et al. Phase angle evaluation of lung disease patients and its relationship with nutritional and functional parameters. J Am Coll Nutr. 2021;40(6):529–534. DOI:10.1080/07315724.2020.1801535
  • Hayden JA, van der Windt DA, Cartwright JL, et al. Assessing bias in studies of prognostic factors. Ann Intern Med. 2013;158(4):280–286. DOI:10.7326/0003-4819-158-4-201302190-00009
  • Grooten WJA, Tseli E, Ang BO, et al. Elaborating on the assessment of the risk of bias in prognostic studies in pain rehabilitation using QUIPS-aspects of interrater agreement. Diagn Progn Res. 2019;3:5. DOI:10.1186/s41512-019-0050-0
  • Barreiro E, Sancho-Munoz A, Puig-Vilanova E, et al. Differences in micro-RNA expression profile between vastus lateralis samples and myotubes in COPD cachexia. J Appl Physiol (1985). 2019;126(2):403–412. DOI:10.1152/japplphysiol.00611.2018
  • Ling CH, de Craen AJ, Slagboom PE, et al. Accuracy of direct segmental multi-frequency bioimpedance analysis in the assessment of total body and segmental body composition in Middle-aged adult population. Clin Nutr. 2011;30(5):610–615. DOI:10.1016/j.clnu.2011.04.001
  • Fonseca FR, Karloh M, Araujo CLP, et al. Validation of a bioelectrical impedance analysis system for body composition assessment in patients with COPD. J Bras Pneumol. 2018;44(4):315–320. DOI:10.1590/s1806-37562017000000121
  • Franssen FM, Rutten EP, Groenen MT, et al. New reference values for body composition by bioelectrical impedance analysis in the general population: results from the UK biobank. J Am Med Dir Assoc. 2014;15(6):448e1-6.
  • Kyle UG, Schutz Y, Dupertuis YM, et al. Body composition interpretation: contributions of the fat-free mass index and the body fat mass index. Nutrition. 2003;19(7–8):597–604. DOI:10.1016/S0899-9007(03)00061-3
  • Sava F, Laviolette L, Bernard S, et al. The impact of obesity on walking and cycling performance and response to pulmonary rehabilitation in COPD. BMC Pulm Med. 2010;10:55. DOI:10.1186/1471-2466-10-55
  • Maatman RC, Spruit MA, van Melick PP, et al. Effects of obesity on weight-bearing versus weight-supported exercise testing in patients with COPD. Respirology. 2016;21(3):483–488. DOI:10.1111/resp.12700
  • Ciavaglia CE, Guenette JA, Ora J, et al. Does exercise test modality influence dyspnoea perception in obese patients with COPD? Eur Respir J. 2014;43(6):1621–1630. DOI:10.1183/09031936.00151513
  • Jaitovich A, Barreiro E. Skeletal muscle dysfunction in chronic obstructive pulmonary disease. What We know and can do for our patients. Am J Respir Crit Care Med. 2018;198(2):175–186. DOI:10.1164/rccm.201710-2140CI
  • Kim HC, Mofarrahi M, Hussain SN. Skeletal muscle dysfunction in patients with chronic obstructive pulmonary disease. Int J Chron Obstruct Pulmon Dis. 2008;3(4):637–658. DOI:10.2147/copd.s4480
  • Hopkinson NS, Tennant RC, Dayer MJ, et al. A prospective study of decline in fat free mass and skeletal muscle strength in chronic obstructive pulmonary disease. Respir Res. 2007;8:25. DOI:10.1186/1465-9921-8-25
  • Spruit MA, Singh SJ, Garvey C, et al. An official American Thoracic Society/European Respiratory Society statement: key concepts and advances in pulmonary rehabilitation. Am J Respir Crit Care Med. 2013;188(8):e13–64. DOI:10.1164/rccm.201309-1634ST